共 91 条
[1]
Velásquez GE(2011)Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005–2008 Emerg Infect Dis 17 432-1505
[2]
Yagui M(2016)The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review BMC Infect Dis 16 193-239
[3]
Cegielski JP(2012)Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test J Vis Exp 62 e3547-171
[4]
Asencios L(2011)Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study Lancet 377 1495-401
[5]
Bayona J(2014)A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town PLoS One 9 e103328-334
[6]
Bonilla C(2006)The global plan to stop TB, 2006–2015 Int J Tuberc Lung Dis 10 238-1437
[7]
Harris RC(2001)The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis Respir Res 2 164-843
[8]
Grandjean L(2015)Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa Int J Tuberc Lung Dis 19 163-638
[9]
Martin LJ(2016)A study to identify the factors responsible for the delay in treatment initiation of MDR–TB cases registered under RNTCP in a district of South India Int J Scient Res 5 397-6
[10]
Miller AJ(2005)Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study BMC Infect Dis 5 112-363